These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32569181)

  • 1. Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
    Michalska A; Gorczyca I; Chrapek M; Kapłon-Cieślicka A; Uziębło-Życzkowska B; Starzyk K; Jelonek O; Budnik M; Gawałko M; Krzesiński P; Jurek A; Scisło P; Kochanowski J; Kiliszek M; Gielerak G; Filipiak KJ; Opolski G; Wożakowska-Kapłon B
    Medicine (Baltimore); 2020 Jun; 99(25):e20570. PubMed ID: 32569181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban.
    Gorczyca I; Chrapek M; Jelonek O; Michalska A; Kapłon-Cieślicka A; Uziębło-Życzkowska B; Budnik M; Gawałko M; Krzesiński P; Jurek A; Scisło P; Kochanowski J; Kiliszek M; Gielerak G; Filipiak KJ; Opolski G; Wożakowska-Kapłon B
    Cardiol Res Pract; 2020; 2020():1206402. PubMed ID: 33014453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registry.
    Gorczyca I; Michalska A; Chrapek M; Budnik M; Starzyk K; Jelonek O; Uziębło-Życzkowska B; Kapłon-Cieślicka A; Gawałko M; Krzesiński P; Jurek A; Scisło P; Kochanowski J; Kiliszek M; Gielerak G; Filipiak KJ; Opolski G; Wożakowska-Kapłon B
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2005-2012. PubMed ID: 32458520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Kapłon-Cieślicka A; Budnik M; Gawałko M; Peller M; Gorczyca I; Michalska A; Babiarz A; Bodys A; Uliński R; Żochowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Heart; 2019 Sep; 105(17):1310-1315. PubMed ID: 31040170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2018 Jul; 122(1):69-75. PubMed ID: 29681367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the predictors of left atrial appendage thrombus between men and women treated with dabigatran or rivaroxaban.
    Ciba-Stemplewska A; Gorczyca-Głowacka I; Kapłon-Cieślicka A; Uziębło-Życzkowska B; Budnik M; Gawałko M; Krzesiński P; Jurek A; Scisło P; Filipiak KJ; Opolski G; Wożakowska-Kapłon B
    Pol Arch Intern Med; 2022 Sep; 132(9):. PubMed ID: 35916361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Lin C; Quan J; Bao Y; Hua W; Ke M; Zhang N; Jin Q; Xie Y; Wei Y; Ling T; Pan W; Wu L; Xie Y
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia.
    Janion-Sadowska A; Papuga-Szela E; Łukaszuk R; Chrapek M; Undas A
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):153-160. PubMed ID: 29985282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.
    Gunawardene MA; Dickow J; Schaeffer BN; Akbulak RÖ; Lemoine MD; Nührich JM; Jularic M; Sinning C; Eickholt C; Meyer C; Moser JM; Hoffmann BA; Willems S
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
    BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Staerk L; Fosbøl EL; Lip GYH; Lamberts M; Bonde AN; Torp-Pedersen C; Ozenne B; Gerds TA; Gislason GH; Olesen JB
    Eur Heart J; 2017 Mar; 38(12):907-915. PubMed ID: 27742807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study.
    Rutherford OW; Jonasson C; Ghanima W; Söderdahl F; Halvorsen S
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):75-85. PubMed ID: 31942972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M; Vedovati MC; Verdecchia P; Pierpaoli L; Verso M; Conti S; Cianella F; Marchesini E; Filippucci E; Agnelli G; Becattini C
    Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter.
    Shah M; Mobaligh N; Niku A; Shiota T; Siegel RJ; Rader F
    Int J Cardiol; 2020 Oct; 317():86-90. PubMed ID: 32344001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of left atrial appendage thrombus and spontaneous echo contrast on transesophageal echocardiography in patients scheduled for pulmonary vein isolation.
    Mannewald C; Roijer A; Platonov PG; Holmqvist F
    Ann Noninvasive Electrocardiol; 2024 May; 29(3):e13119. PubMed ID: 38682420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion.
    Gawałko M; Kapłon-Cieślicka A; Budnik M; Babiarz A; Bodys A; Uliński R; Żochowski M; Peller M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Pol Arch Intern Med; 2017 Dec; 127(12):823-831. PubMed ID: 28972957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
    Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
    Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.